ANI-7 structure
|
Common Name | ANI-7 | ||
---|---|---|---|---|
CAS Number | 931417-26-4 | Molecular Weight | 263.121 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C13H8Cl2N2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ANI-7A potent and selective (up to 263-fold) inhibitor of breast cancer cells with GI50 of 0.5 uM (MCF-7), via activation the aryl hydrocarbon receptor (AhR) pathway; inhibits other cell lines derived from other tumour types with GI50 of 3.2-46 uM (lung, colon, ovary, neuronal, glial, prostate, and pancreas); potently inhibits the growth of T47D, ZR-75-1, MCF-7, SKBR3, and MDA-MB-468 breast cancer cells with GI50 of 0.16-0.38 uM, induces cell cycle arrest checkpoint activation and DNA damage; binds to the AhR, induces translocation to the nucleus, activates the XRE, induces CYP1 activity, culminating in cell cycle arrest, checkpoint activation, DNA damage and cell death. |
Name | ANI-7 |
---|
Description | A potent and selective (up to 263-fold) inhibitor of breast cancer cells with GI50 of 0.5 uM (MCF-7), via activation the aryl hydrocarbon receptor (AhR) pathway; inhibits other cell lines derived from other tumour types with GI50 of 3.2-46 uM (lung, colon, ovary, neuronal, glial, prostate, and pancreas); potently inhibits the growth of T47D, ZR-75-1, MCF-7, SKBR3, and MDA-MB-468 breast cancer cells with GI50 of 0.16-0.38 uM, induces cell cycle arrest checkpoint activation and DNA damage; binds to the AhR, induces translocation to the nucleus, activates the XRE, induces CYP1 activity, culminating in cell cycle arrest, checkpoint activation, DNA damage and cell death. |
---|---|
References | References 1. Gilbert J, et al. Mol Pharmacol. 2017 Dec 21. pii: mol.117.109827. View Related Products by Target Aryl hydrocarbon Receptor (AhR) |
Molecular Formula | C13H8Cl2N2 |
---|---|
Molecular Weight | 263.121 |